(+)-Biotin

FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments

This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s

DMF submissions reveal no slowdown in India & China

Every quarter, PharmaCompass compiles the latest Drug Master Files (DMFs) submitted to the US Food a